News Agency
Men's Weekly

Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer

  • Written by PR Newswire

SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Phase III bridging clinical trial of Hexvix® for bladder cancer...

Read more: Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer

How Downsizing to a Caravan Can Transform Your Lifestyle

If you’re curious about simplifying life while keeping the sense of adventure, caravan and camping sales offer an inviting gateway. Downsizing to a caravan can transform your daily routine from wrangling a cluttered house every morning to a more manageable... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion